ABOUT THE JOURNAL
Aims and scope of journal |Impact factor |
Abstracted/indexed in |
ISSN and eISSN |
Editors |
Top of page
Aims and scope of journal
Leukemia covers all aspects of the research and treatment of Leukemia and Allied Diseases. Studies of normal hemopoiesis are covered because of their comparative relevance. Topics of interest include oncogenes, growth factors, stem cells, leukemia genomics, cell cycle, signal transduction, molecular targets for therapy and more.
Top of pageImpact Factor
2007 Impact Factor: 6.924*
Rank:
6/63 Hematology
13/132 Oncology
* Journal Citation Reports, Thomson Reuters, 2008
Top of pageAbstracted/indexed in
BIOBASE/Current Awareness in Biological Sciences
BIOSIS
Cambridge Scientific Abstracts
Current Advances in Cell and Developmental Biology
Current Advances in Genetics and Molecular Biology
Current Contents
Current Contents/Life Sciences
EMBASE/Excerpta Medica
MEDLINE/Index Medicus
Research Alert
Reference Update
Science Citation Index
Science Citation Index Expanded
SUBIS
ISSN and eISSN
The international standard serial number (ISSN) for Leukemia is 0887-6924, and the electronic international standard serial number (eISSN) is 1476-5551.
Top of pageEditors
Editor-in-Chief
N Muller-Bérat Killmann, M.D, France
Section Editors
Acute Promyelocytic Leukemia: M Lanotte, France; A Melnick, USA; R Ohno, Japan
Apoptosis: D E Johnson, USA
Bone Marrow Transplantation: A Nagler, Israel
Chimerism and Transplant-related Diagnostics: T Lion, Austria
Chronic Myeloid Leukemia: A Hochhaus, Germany; A Quintas-Cardama, USA
Clinical Studies (Adult Leukemia): J Rowe, Israel; X Thomas, France
CLL and B cell malignancies: J Dürig, Germany
Genetic Profiles and Microarrays: A Ferrando, USA; F J T Staal, The Netherlands
Immunity: P Brossart, Germany
Immunophenotyping: M J Borowitz, USA
Leukemogenomics: J A McCubrey, USA; N Muller-Bérat Killmann, France
Lymphoma: R Siebert, Germany; D Sternberg, USA
Molecular Cytogenetics: C Harrison, UK; K Mrozek, USA
Molecular Targets for Therapy; Basic aspects and therapeutic implications: N Muller-Bérat Killmann, France in conjunction with J A McCubrey, USA; D E Johnson, USA; J D Licht, USA; D Sternberg, USA; B van der Reijden, The Netherlands
Myelodysplasias: T de Witte, The Netherlands; H J Deeg, USA; G Garcia-Manero, USA
Myeloma: S V Rajkumar, USA; H Avet-Loiseau, France
Myeloproliferative Disorders: A Tefferi, USA
New Directions in Stem Cell Research: M Z Ratajczak, USA
Pediatric Hemopathies: C H Pui, USA
Pharmacodynamics and Pharmacogenomics: W K Plunkett, USA
Signal Transduction and Cytokines: SN Constantinescu, Belgium; J A McCubrey, USA; T Naoe, Japan; D Sternberg, USA
Transcriptional Control and Deregulation: J D Licht, USA; B van der Reijden, The Netherlands
Editorial Board
J Abkowitz, USA
K C Anderson, USA
M Andreef, USA
P Aplan, USA
S Armstrong, USA
P Bader, Germany
C Baum, Germany
W E Berdel, Germany
O A Bernard, France
C Buske, Germany
G Calin, USA
D Campana, USA
F Cervantes, Spain
Z Chen, China
T Cheng, USA
G Cohen, UK
J E Cortes, USA
U Creutzig, Germany
N Cross, UK
F Dazzi, UK
C Deng, China
T Fioretos, Sweden
R Fonseca, USA
P Ghia, Italy
A Hagemeijer, Belgium
S Hunger, USA
F Ishikawa, Japan
N E Kay, USA
K Le Blanc, Sweden
F Lo Coco, Italy
A Martelli, Italy
C Melief, The Netherlands
D Metcalf, Australia
M Mohty, France
J Molldrem, USA
C Nervi, Italy
D Neuberg, USA
K Ohyashiki, Japan
N Panoskaltsis, UK
E Passegue, USA
B Payrastre, France
J Pederson-Bjergaard, Denmark
M A Piris, Spain
MHGP Raaijmakers, USA
A Reiter, Germany
M V Relling, USA
D Ribatti, Italy
J D Rowley, USA
D Scheinberg, USA
R Schlenk, Germany
A Shimoni, Israel
T Skorski, USA
B D Smith, USA
D E Spaner, Canada
F Speleman, Belgium
C Steward, UK
C A Stiller, UK
T Szczepanski, Poland
J Thiele, Germany
M Tilanus, The Netherlands
JJM van Dongen, The Netherlands
D Weisdorf, USA
M C Yoder, USA
Honorary Members
J Freireich, USA
C Rozman, Spain
D van Bekkum, The Netherlands
Founding Editors
Nicole Muller-Bérat Killman, M.D. and Sven-Aage Killman, M.D.